PAA 4.88% 21.5¢ pharmaust limited

Ann: Progress update on Phase 1/2 MND interim analysis, page-60

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,418 Posts.
    lightbulb Created with Sketch. 1504
    ".,.. so it's mnd and now the old carrots being brought out of retirement human cancer and covid to be dangled in front of investors."

    Old carrots
    Bucky? Human cancer treatment was always the goal. The current human MND trial always had a dual purpose of testing monepantel's potential against MND and to be the default phase one clinical trial for human cancer and covid.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.5¢
Change
0.010(4.88%)
Mkt cap ! $104.6M
Open High Low Value Volume
20.5¢ 21.5¢ 20.5¢ $244.1K 1.163M

Buyers (Bids)

No. Vol. Price($)
3 71981 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 84173 3
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.